Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-γ, pioglitazone

被引:83
|
作者
Enomoto, N [1 ]
Takei, Y [1 ]
Hirose, M [1 ]
Konno, A [1 ]
Shibuya, T [1 ]
Matsuyama, S [1 ]
Suzuki, S [1 ]
Ikejima, K [1 ]
Kitamura, T [1 ]
Sato, N [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138421, Japan
关键词
D O I
10.1124/jpet.102.047217
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonists of peroxisome proliferator-activated receptor (PPAR)-gamma have been shown to reduce tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance. On the other hand, sensitization of Kupffer cells to lipopolysaccharide (LPS) and their production of TNF-alpha are critical for progression of alcoholic liver injury. This study was intended to determine whether pioglitazone, a PPAR-gamma agonist, could prevent alcohol-induced liver injury. Rats were given ethanol (5 g/kg b.wt.) and pioglitazone (500 mug/kg) once every 24 h intragastrically. Ethanol for 8 weeks caused pronounced steatosis, necrosis, and inflammation in the liver. These pathological parameters were diminished greatly by pioglitazone. Kupffer cells were sensitized to LPS after ethanol for 4 weeks as evidenced by aggravation of liver pathology induced by LPS (5 mg/kg) and enhancement of LPS (100 ng/ml)-induced intracellular Ca2+ concentration elevation in Kupffer cells. The parameters were diminished by treatment with pioglitazone. LPS-induced TNF-alpha production by Kupffer cells from the 4-week ethanol group was 3 to 4 times higher than control. This increase was blunted by 70% with pioglitazone. Gut permeability was 10-fold higher in the 4-week ethanol group, and pioglitazone treatment did not change the value. Inclusion of TNF-alpha in culture media of Kupffer cells enhanced CD14 expression, LPS-induced intracellular Ca2+ concentration response, and production of TNF-alpha. These results indicate that pioglitazone prevents alcoholic liver injury through abrogation of Kupffer cell sensitization to LPS.
引用
收藏
页码:846 / 854
页数:9
相关论文
共 50 条
  • [41] Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-γ ligand, on lung ischemia-reperfusion injury in rats
    Ito, K
    Shimada, J
    Kato, D
    Toda, S
    Takagi, T
    Naito, Y
    Yoshikawa, T
    Kitamura, N
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (04) : 530 - 536
  • [43] Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ
    Narala, Venkata R.
    Smith, Monica R.
    Adapala, Ravi K.
    Ranga, Rajesh
    Panati, Kalpana
    Moore, Bethany B.
    Leff, Todd
    Reddy, Vudem D.
    Kondapi, Anand K.
    Reddy, Raju C.
    GENE THERAPY AND MOLECULAR BIOLOGY, 2009, 13 (01): : 20 - 25
  • [44] Peroxisome proliferator-activated receptor-α -: Friend or foe?
    Yagil, Chana
    Yagil, Yoram
    HYPERTENSION, 2007, 50 (05) : 847 - 850
  • [45] Peroxisome proliferator-activated receptor-γ and esophageal cancer
    Shimada, T
    Terano, A
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 140 (01): : 4 - 5
  • [46] Peroxisome proliferator-activated receptor-γ in the renal mesangium
    Hsueh, WA
    Nicholas, SB
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (02): : 191 - 195
  • [47] Peroxisome proliferator-activated receptor-? cofactors in neurodegeneration
    Katsouri, Loukia
    Blondrath, Katrin
    Sastre, Magdalena
    IUBMB LIFE, 2012, 64 (12) : 958 - 964
  • [48] Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Vita, Roberto
    Antonelli, Alessandro
    Benvenga, Salvatore
    PPAR RESEARCH, 2015, 2015
  • [49] Peroxisome proliferator-activated receptor-γ expression in lung
    Inoue, K
    Kawahito, Y
    Sano, H
    CHEST, 2002, 122 (01) : 386 - 387
  • [50] Attenuation of hypoxia-induced pulmonary artery remodeling by a peroxisome proliferator-activated receptor-γ agonist
    Crossno, JT
    Morris, KG
    Klemm, DJ
    CHEST, 2005, 128 (06) : 580S - 580S